Admissibility Hurdles for 510(k) Evidence in Medical Device Litigation
"12 C.Medtronic, Inc. v. Lohr: Contrasting 510(k) and PMA The U.S. Supreme Court's 1996 opinion in Medtronic, Inc. v. Lohr,13 rooted in an analysis of whether certain state law claims were preempted under 21 U.S.C. 360k(a), quickly became the touchstone for any examination of the FDA'...
Saved in:
Published in | Defense counsel journal Vol. 87; no. 1; pp. 1 - 11 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Chicago
International Association of Defense Counsels
01.01.2020
International Association of Defense Counsel |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | "12 C.Medtronic, Inc. v. Lohr: Contrasting 510(k) and PMA The U.S. Supreme Court's 1996 opinion in Medtronic, Inc. v. Lohr,13 rooted in an analysis of whether certain state law claims were preempted under 21 U.S.C. 360k(a), quickly became the touchstone for any examination of the FDA's regulatory scheme for medical devices in federal court. [...]substantial equivalence determinations provide little protection to the public. III.Admissibility Trends A. Appellate Decisions Excluding 510(k) Evidence Plaintiffs arguing for the exclusion of 510(k) evidence received a boost from the Eleventh Circuit in Eghnayem v. Boston Scientific Corp.17 In affirming a final judgment in favor of the plaintiff who alleged injuries caused by a transvaginal mesh prescription medical device, the court explained: "[I]t is clear that the district court did not abuse its discretion when it concluded that the 510(k) review process is not relevant to a product's safety. "18 The court further agreed with the district court's explanation that, "if 510(k) does not go to a product's safety and efficacy - the very subjects of the plaintiff's products liability claims - then evidence of [the manufacturer's] compliance with 510(k) has no relevance to the state law claims in this case. |
---|---|
ISSN: | 0895-0016 2376-3906 |